CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Extension Study to Evaluate the Long-Term Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05479981
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:12.624333+00:00
Published At: 2025-10-08T00:00:00+00:00
Record Updated At: 2025-10-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["DM1", "Muscular Dystrophies", "Myotonic Dystrophy", "Myotonic Dystrophy 1", "Myotonic Disorders", "Muscular Disorders, Atrophic", "Muscular Diseases", "Musculoskeletal Diseases", "Neuromuscular Diseases", "Nervous System Diseases", "Genetic Diseases, Inborn", "Heredodegenerative Disorders, Nervous System", "Neurodegenerative Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-10-08"
protocolSection.identificationModule.nctId: "NCT05479981"
protocolSection.identificationModule.officialTitle: "A Phase 2 Extension Study to Evaluate the Long-Term Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.